動物 API (API) 市場：按治療類別、合成類型、合同外包類型、藥物類型分類——到 2032 年的全球預測

在寵物保險需求不斷增長的推動下，預計到 2032 年，全球動物 API (API) 市場將顯著增長。

例如，據一位消息人士透露，2021 年美國投保的寵物總數將達到 390 萬隻，比 2020 年增長 28%。

預計到 2032 年，寵物保險行業政府舉措的增加也將刺激市場需求。 例如，在 2019 年，NAIC 接受了一項製定示範法的請求，以解決諸如報銷福利、預先存在的條件、定義、違規、生產者許可證、披露和與寵物保險相關的法規等問題。

在另一個例子中，動物健康和獸醫信息的權威來源 VETMED 發布了動物原料藥 (API)，宣布將對（成分）的環境發生進行量化。 VETMED 表示，這筆交易將使其能夠更好地了解這些藥物的重要性。

總體而言，全球獸用 API (API) 市場按治療類別、合成、合同外包、藥物和區域進行細分。

根據治療類別，市場預計將以非甾體抗炎藥細分市場為特徵，該細分市場在 2022 年的估值將超過 56 億美元。 非甾體抗炎藥越來越多地用於控制動物的疼痛、發燒和其他炎症跡象。 一項研究證實，英國獸醫通常使用 NSAIDs（非甾體抗炎藥）來治療狗的骨關節炎。

基於合成，生物原料藥部門將在 2022 年佔超過 107 億美元的收入份額，並在未來十年實現強勁增長。 該細分市場的擴張是由於對用於診斷和治療動物各種健康問題的生物活性物質的需求不斷增長。 此外，屬於治療藥物類別的疾病數量正在增加，這將是細分市場擴張的推動力。

基於合同外包，CDMO 部分將在 2023 年至 2032 年間顯著增長。 由於 CDMO 為動物 API 提供的優勢和好處，這導致了更多的採用。

在醫藥領域，處方藥領域預計將從 2023 年到 2032 年顯著增長。 該細分市場的增長預計將受到各種處方藥和治療藥物（如抗感染藥、非甾體抗炎藥、抗生素和治療嚴重疾病的疫苗）使用量激增的推動。

按地區劃分，由於人畜共患疾病流行的加劇和有利的國家監管情景，全球動物原料藥 (API) 市場預計將在北美強勁增長。

內容

第 1 章研究方法和範圍

第 2 章執行摘要

第 3 章：動物 API (API) 的行業洞察

• 按行業細分
• 行業格局，2018-2032 年版
• 影響行業的因素
  • 司機
    • 對寵物保險的需求不斷增長
    • 提高了對動物健康和身心健康的認識
    • 對畜產品的需求增加
    • 積極的政府舉措
    • 飼養寵物
  • 行業潛在的風險和挑戰
    • 自付費用較低的獸醫費用
    • 獸藥成本高
• 增長分析
  • 按治療類別
  • 按合成類型
  • 按合同外包類型
  • 按藥物類型
• COVID-19 影響分析
• 技術概況
• 供應鏈分析
• 主要市場趨勢
• 管道解析
• 監管狀況
  • 美國
  • 歐洲
  • 亞太地區
• 供應商矩陣分析
• 波特分析
• PESTEL 分析

第 4 章競爭格局，2021 年

• 簡介
• 2021 年公司矩陣分析
• 戰略儀表板，2021 年

第 5 章動物 API 市場：按治療類別分類

• 主要細分趨勢
• 抗感染藥
• 抗寄生蟲藥
• 非甾體抗炎藥
• 生物製劑
• 其他

第 6 章動物 API 市場：按合成類型

• 主要細分趨勢
• 化學原料藥
• 生物原料藥
• 高活性 API (HPAPI)

第 7 章動物 API (API) 市場：按合同外包類型

• 主要細分趨勢
• CDMO
• 首席營銷官

第 8 章動物 API 市場：按藥物類型分類

• 主要細分趨勢
• 處方
• 場外交易

第 9 章動物原料藥 (API) 市場：按地區

• 主要區域趨勢
• 北美
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 意大利
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳大利亞
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙特阿拉伯
  • 阿聯酋

第十章公司簡介

• Alivira Animal Health Ltd
• SUANFARMA
• Procyon Life Sciences
• Jiangsu Lingyun Pharmaceutical Co., Ltd
• Ofichem Group
• NGL Fine-Chem Ltd
• Huvepharma
• Excel Veterinary Healthcare
• Menadiona
• Indukern Group
• Vetpharma（Insud Pharma）
• Qilu Pharmaceutical（Inner Mongolia）Co., Ltd

Global Veterinary Active Pharmaceutical Ingredients Market is poised to grow significantly through 2032, owing to the increasing demand for pet insurance. For instance, according to a source, the total number of pets that were insured in the U.S. in 2021 was 3.9 million, depicting an increase of 28% from 2020.

Besides, an upsurge in favorable government initiatives in the pet insurance industry will fuel the market demand by 2032. To cite an instance, the NAIC in 2019 accepted the request for Model Law development to address issues such as reimbursement benefits, pre-existing conditions, definitions, violations, producer licensing, disclosures, and regulations regarding pet insurance.

In another instance, VETMED, a reliable source for animal health and veterinary medicine announced quantifying the environmental occurrence of veterinary active pharmaceutical ingredients to better understand the scope of active pharmaceutical ingredients and the spreading of antimicrobial resistance. VETMED claims that the deal will help it to better understand the significance of these medications.

Overall, the global veterinary active pharmaceutical ingredients market is segmented in terms of therapeutic category, synthesis, contract outsourcing, drug, and region.

Based on the therapeutic category, the market is likely to be characterized by the NSAIDs segment, which held a valuation of more than USD 5.6 billion in 2022. NSAIDs are increasingly used to control pain, fever, and other signs of inflammation in animals. A study observed that NSAIDs (Non-steroidal anti-inflammatory drugs) are commonly used to treat canine osteoarthritis by veterinary surgeons in the UK.

Based on synthesis, the biological API segment held more than USD 10.7 billion revenue share in 2022 and will grow robustly over the next ten years. The segmental expansion can be credited to the growing demand for biologically active substances which are used to diagnose and treat various health issues among animals. Besides, there is a rise in the number of diseases in the therapeutic category, which will drive segmental expansion.

On the basis of contract outsourcing, the CDMO segment will grow significantly through 2023-2032, owing to the benefits and advantages offered by them to the veterinary APIs, resulting in their increasing adoption.

In the context of the drug, the prescription segment will grow significantly between 2023 and 2032. The growth of this segment is anticipated to be driven by the surging usage of a range of prescribed medications and therapeutics including anti-infectives, NSAIDs, antibiotics, and vaccines, to treat severe ailments.

In the regional context, the global veterinary active pharmaceutical ingredients market will grow significantly in North America, due to the growing prevalence of zoonotic diseases and a favorable State-backed regulatory scenario.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Industry coverage
• 1.2 Market scope & definitions
• 1.3 Base estimates & working
  • 1.3.1 Data collection
• 1.4 Forecast parameters
• 1.5 COVID-19 impact analysis at global level
• 1.6 Data validation
• 1.7 Data sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Veterinary active pharmaceutical ingredients industry 360 degree synopsis, 2018 - 2032
• 2.2 Business trends
  • 2.2.1 Therapeutic category trends
  • 2.2.2 Synthesis type trends
  • 2.2.3 Contract outsourcing type trends
  • 2.2.4 Drug type trends
  • 2.2.5 Regional trends

Chapter 3 Veterinary Active Pharmaceutical Ingredients Industry Insights

• 3.1 Industry segmentation
• 3.2 Industry landscape, 2018 - 2032
• 3.3 Industry impact forces
  • 3.3.1 Growth drivers
    • 3.3.1.1 Increasing demand for pet insurance
    • 3.3.1.2 Surging awareness of animal health, physical and mental well-being
    • 3.3.1.3 Increasing demand for animal products
    • 3.3.1.4 Favorable government initiatives
    • 3.3.1.5 Growing pet adoption
  • 3.3.2 Industry pitfalls & challenges
    • 3.3.2.1 Low out of pocket expenditure on veterinary care
    • 3.3.2.2 High cost of veterinary medicines
• 3.4 Growth potential analysis
  • 3.4.1 By therapeutic category
  • 3.4.2 By synthesis type
  • 3.4.3 By contract outsourcing type
  • 3.4.4 By drug type
• 3.5 COVID-19 impact analysis
• 3.6 Technology landscape
• 3.7 Supply chain analysis
• 3.8 Key market trends
• 3.9 Pipeline analysis
• 3.10 Regulatory landscape
  • 3.10.1 U.S.
  • 3.10.2 Europe
  • 3.10.3 Asia Pacific
• 3.11 Vendor matrix analysis
• 3.12 Porter's analysis
  • 3.12.1 Industry rivalry
  • 3.12.2 Bargaining power of suppliers
  • 3.12.3 Bargaining power of buyers
  • 3.12.4 Threat of substitute
  • 3.12.5 Threat of new entrants
• 3.13 PESTEL analysis
  • 3.13.1 Political
  • 3.13.2 Economical
  • 3.13.3 Social
  • 3.13.4 Technological
  • 3.13.5 Legal
  • 3.13.6 Environmental

Chapter 4 Competitive Landscape, 2021

• 4.1 Introduction
• 4.2 Company matrix analysis, 2021
• 4.3 Strategy dashboard, 2021

Chapter 5 Veterinary Active Pharmaceutical Ingredients Market, By Therapeutic Category

• 5.1 Key segment trends
• 5.2 Anti-infectives
  • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.3 Anti-parasitic
  • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.4 NSAIDs
  • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.5 Biologics
  • 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.6 Others
  • 5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Veterinary Active Pharmaceutical Ingredients Market, By Synthesis Type

• 6.1 Key segment trends
• 6.2 Chemical based API
  • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.3 Biological API
  • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.4 Highly potent API (HPAPI)
  • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Veterinary Active Pharmaceutical Ingredients Market, By Contract Outsourcing Type

• 7.1 Key segment trends
• 7.2 CDMO
  • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 7.3 CMO
  • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Veterinary Active Pharmaceutical Ingredients Market, By Drug Type

• 8.1 Key segment trends
• 8.2 Prescription
  • 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 8.3 OTC
  • 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Veterinary Active Pharmaceutical Ingredients Market, By Region

• 9.1 Key regional trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East & Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Alivira Animal Health Ltd
• 10.2 SUANFARMA
• 10.3 Procyon Life Sciences
• 10.4 Jiangsu Lingyun Pharmaceutical Co., Ltd
• 10.5 Ofichem Group
• 10.6 NGL Fine-Chem Ltd
• 10.7 Huvepharma
• 10.8 Excel Veterinary Healthcare
• 10.9 Menadiona
• 10.10 Indukern Group
• 10.11 Vetpharma (Insud Pharma)
• 10.12 Qilu Pharmaceutical (Inner Mongolia) Co., Ltd

Data Tables

• TABLE 1. Product mapping
• TABLE 2. Market revenue, by therapeutic category (2022)
• TABLE 3. Market revenue, by synthesis type (2022)
• TABLE 4. Market share, by contract outsourcing type (2022)
• TABLE 5. Market share, by drug type (2022)
• TABLE 6. Market share, by region (2022)
• TABLE 7. Global veterinary active pharmaceutical ingredients market, 2018 - 2024 (USD Million)
• TABLE 8. Global veterinary active pharmaceutical ingredients market, 2025 - 2032 (USD Million)
• TABLE 9. Global veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024 (USD Million)
• TABLE 10. Global veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032 (USD Million)
• TABLE 11. Global veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024 (USD Million)
• TABLE 12. Global veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032 (USD Million)
• TABLE 13. Global veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024 (USD Million)
• TABLE 14. Global veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032 (USD Million)
• TABLE 15. Global veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024 (USD Million)
• TABLE 16. Global veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032 (USD Million)
• TABLE 17. Global veterinary active pharmaceutical ingredients market, 2018 - 2024 (USD Million)
• TABLE 18. Global veterinary active pharmaceutical ingredients market, 2025 - 2032 (USD Million)
• TABLE 19. Industry impact forces
• TABLE 20. Comprehensive study of active pharmaceutical ingredients supply chain of the U.S. and Europe
• TABLE 21. Veterinary APIs under development for the manufacturing of animal drugs
• TABLE 22. Application of GMP guidance to API manufacturing
• TABLE 23. Anti-infectives market, 2018 - 2024 (USD Million)
• TABLE 24. Anti-infectives market, 2025 - 2032 (USD Million)
• TABLE 25. Anti-parasitic market, 2018 - 2024 (USD Million)
• TABLE 26. Anti-parasitic market, 2025 - 2032 (USD Million)
• TABLE 27. NSAIDs market, 2018 - 2024 (USD Million)
• TABLE 28. NSAIDs market, 2025 - 2032 (USD Million)
• TABLE 29. Biologics market, 2018 - 2024 (USD Million)
• TABLE 30. Biologics market, 2025 - 2032 (USD Million)
• TABLE 31. Others market, 2018 - 2024 (USD Million)
• TABLE 32. Others market, 2025 - 2032 (USD Million)
• TABLE 33. Chemical based API market, 2018 - 2024 (USD Million)
• TABLE 34. Chemical based API market, 2025 - 2032 (USD Million)
• TABLE 35. Biological API market, 2018 - 2024 (USD Million)
• TABLE 36. Biological API market, 2025 - 2032 (USD Million)
• TABLE 37. Highly potent API (HPAPI) market, 2018 - 2024 (USD Million)
• TABLE 38. Highly potent API (HPAPI) market, 2025 - 2032 (USD Million)
• TABLE 39. CDMO market, 2018 - 2024 (USD Million)
• TABLE 40. CDMO market, 2025 - 2032 (USD Million)
• TABLE 41. CMO market, 2018 - 2024 (USD Million)
• TABLE 42. CMO market, 2025 - 2032 (USD Million)
• TABLE 43. Prescription market, 2018 - 2024 (USD Million)
• TABLE 44. Prescription market, 2025 - 2032 (USD Million)
• TABLE 45. OTC market, 2018 - 2024 (USD Million)
• TABLE 46. OTC market, 2025 - 2032 (USD Million)
• TABLE 47. North America veterinary active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
• TABLE 48. North America veterinary active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
• TABLE 49. North America veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 50. North America veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 51. North America veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 52. North America veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 53. North America veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 54. North America veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 55. North America veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 56. North America veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 57. U.S. veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 58. U.S. veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 59. U.S. veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 60. U.S. veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 61. U.S. veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 62. U.S. veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 63. U.S. veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 64. U.S. veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 65. Canada veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 66. Canada veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 67. Canada veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 68. Canada veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 69. Canada veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 70. Canada veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 71. Canada veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 72. Canada veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 73. Europe veterinary active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
• TABLE 74. Europe veterinary active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
• TABLE 75. Europe veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 76. Europe veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 77. Europe veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 78. Europe veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 79. Europe veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 80. Europe veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 81. Europe veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 82. Europe veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 83. Germany veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 84. Germany veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 85. Germany veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 86. Germany veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 87. Germany veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 88. Germany veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 89. Germany veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 90. Germany veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 91. UK veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 92. UK veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 93. UK veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 94. UK veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 95. UK veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 96. UK veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 97. UK veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 98. UK veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 99. France veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 100. France veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 101. France veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 102. France veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 103. France veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 104. France veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 105. France veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 106. France veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 107. Spain veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 108. Spain veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 109. Spain veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 110. Spain veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 111. Spain veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 112. Spain veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 113. Spain veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 114. Spain veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 115. Italy veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 116. Italy veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 117. Italy veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 118. Italy veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 119. Italy veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 120. Italy veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 121. Italy veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 122. Italy veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 123. Asia Pacific veterinary active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
• TABLE 124. Asia Pacific veterinary active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
• TABLE 125. Asia Pacific veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 126. Asia Pacific veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 127. Asia Pacific veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 128. Asia Pacific veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 129. Asia Pacific veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 130. Asia Pacific veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 131. Asia Pacific veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 132. Asia Pacific veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 133. China veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 134. China veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 135. China veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 136. China veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 137. China veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 138. China veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 139. China veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 140. China veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 141. Japan veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 142. Japan veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 143. Japan veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 144. Japan veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 145. Japan veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 146. Japan veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 147. Japan veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 148. Japan veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 149. India veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 150. India veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 151. India veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 152. India veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 153. India veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 154. India veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 155. India veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 156. India veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 157. Australia veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 158. Australia veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 159. Australia veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 160. Australia veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 161. Australia veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 162. Australia veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 163. Australia veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 164. Australia veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 165. South Korea veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 166. South Korea veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 167. South Korea veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 168. South Korea veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 169. South Korea veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 170. South Korea veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 171. South Korea veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 172. South Korea veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 173. Latin America veterinary active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
• TABLE 174. Latin America veterinary active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
• TABLE 175. Latin America veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 176. Latin America veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 177. Latin America veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 178. Latin America veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 179. Latin America veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 180. Latin America veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 181. Latin America veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 182. Latin America veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 183. Brazil veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 184. Brazil veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 185. Brazil veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 186. Brazil veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 187. Brazil veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 188. Brazil veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 189. Brazil veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 190. Brazil veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 191. Mexico veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 192. Mexico veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 193. Mexico veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 194. Mexico veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 195. Mexico veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 196. Mexico veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 197. Mexico veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 198. Mexico veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 199. Argentina veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 200. Argentina veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 201. Argentina veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 202. Argentina veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 203. Argentina veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 204. Argentina veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 205. Argentina veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 206. Argentina veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 207. MEA veterinary active pharmaceutical ingredients market, by country, 2018 - 2024, (USD Million)
• TABLE 208. MEA veterinary active pharmaceutical ingredients market, by country, 2025 - 2032, (USD Million)
• TABLE 209. MEA veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 210. MEA veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 211. MEA veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 212. MEA veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 213. MEA veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 214. MEA veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 215. MEA veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 216. MEA veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 217. South Africa veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 218. South Africa veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 219. South Africa veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 220. South Africa veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 221. South Africa veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 222. South Africa veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 223. South Africa veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 224. South Africa veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 225. Saudi Arabia veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 226. Saudi Arabia veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 227. Saudi Arabia veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 228. Saudi Arabia veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 229. Saudi Arabia veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 230. Saudi Arabia veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 231. Saudi Arabia veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 232. Saudi Arabia veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)
• TABLE 233. UAE veterinary active pharmaceutical ingredients market, by therapeutic category, 2018 - 2024, (USD Million)
• TABLE 234. UAE veterinary active pharmaceutical ingredients market, by therapeutic category, 2025 - 2032, (USD Million)
• TABLE 235. UAE veterinary active pharmaceutical ingredients market, by synthesis type, 2018 - 2024, (USD Million)
• TABLE 236. UAE veterinary active pharmaceutical ingredients market, by synthesis type, 2025 - 2032, (USD Million)
• TABLE 237. UAE veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2018 - 2024, (USD Million)
• TABLE 238. UAE veterinary active pharmaceutical ingredients market, by contract outsourcing type, 2025 - 2032, (USD Million)
• TABLE 239. UAE veterinary active pharmaceutical ingredients market, by drug type, 2018 - 2024, (USD Million)
• TABLE 240. UAE veterinary active pharmaceutical ingredients market, by drug type, 2025 - 2032, (USD Million)

Charts & Figures

• FIG. 1 GMI report coverage: Critical research elements
• FIG. 2 Industry segmentation
• FIG. 3 Top-down approach
• FIG. 4 Market estimation and forecast methodology
• FIG. 5 Market forecasting methodology
• FIG. 6 Breakdown of primary participants
• FIG. 7 Veterinary active pharmaceutical ingredients industry 360 degree synopsis, 2018 - 2032
• FIG. 8 Industry landscape, 2018 - 2032 (USD Million)
• FIG. 9 Growth potential analysis, by therapeutic category
• FIG. 10 Growth potential analysis, by synthesis type
• FIG. 11 Growth potential analysis, by contract outsourcing type
• FIG. 12 Growth potential analysis, by drug type
• FIG. 13 Supply chain based on traditional veterinary API manufacturing
• FIG. 14 Porter's analysis
• FIG. 15 PESTEL analysis
• FIG. 16 Company matrix analysis, 2021
• FIG. 17 Strategy dashboard, 2021